Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CFO
Pharma
Moderna recorded better-than-expected COVID shot sales in Q2
In 2025's second quarter, Moderna recorded total revenues of $142 million, down roughly 41% versus 2025, against a net loss of $825 million.
Fraiser Kansteiner
Aug 1, 2025 11:00am
Teva execs aren't sweating newly unveiled pharmaceutical tariffs
Jul 30, 2025 11:11am
GSK revs up launch plans after Nucala's FDA approval in COPD
May 22, 2025 3:10pm
Teva plots layoffs as restructuring drive enters new phase
May 8, 2025 9:55am
Lilly taps longtime company veteran to fill finance chief role
Sep 9, 2024 10:28am
Eli Lilly names company vet Gordon Brooks as interim CFO
Jul 10, 2024 10:48am
